Exact Sciences
EXAS
#1653
Rank
$8.20 B
Marketcap
$46.18
Share price
1.38%
Change (1 day)
-44.60%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: $8.20 Billion

As of December 2022 Exact Sciences has a market cap of $8.20 Billion. This makes Exact Sciences the world's 1653th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$8.20 B-39.3%
2021$13.51 B-32.18%
2020$19.92 B45.98%
2019$13.65 B75.63%
2018$7.77 B23.57%
2017$6.29 B334.33%
2016$1.44 B62.32%
2015$0.89 B-63.31%
2014$2.43 B191.21%
2013$0.83 B23.39%
2012$0.67 B57.47%
2011$0.42 B37.78%
2010$0.31 B159.03%
2009$0.12 B675.37%
2008$15.53 M-82.23%
2007$87.39 M15.32%
2006$75.78 M29.71%
2005$58.42 M-41.97%
2004$0.10 B-48.48%
2003$0.19 B-5.4%
2002$0.20 B7.42%
2001$0.19 B

End of Day market cap according to different sources

On Dec 6th, 2022 the market cap of Exact Sciences was reported to be:

$7.95 Billion
by Yahoo Finance
$8.20 Billion
by CompaniesMarketCap
$8.20 Billion
by Nasdaq
$8.20 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$124.84 B 1,421.46%๐Ÿ‡ซ๐Ÿ‡ท France
$2.09 B-74.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.95 B-88.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.58 B-80.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.11 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA